KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy

BACKGROUND: This study was carried out to evaluate the prognostic value of KIBRA in breast cancer. METHODS: This retrospective study included breast cancer patients who sought the services of the immunohistochemistry laboratory of our unit from 2006 to 2015. Tissue microarrays were constructed and i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Mudduwa, Lakmini, Peiris, Harshini, Gunasekara, Shania, Abeysiriwardhana, Deepthika, Liyanage, Nimsha, Rayala, Suresh K., Liyanage, Thusharie
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5968668/
https://ncbi.nlm.nih.gov/pubmed/29793439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4491-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars